Authorities in China have approved a drug for the treatment of Alzheimer's disease. It's the first new medicine with the potential to treat the cognitive disorder in 17 years.
Authorities in China have approved a drug for the treatment of Alzheimer's disease, the first new medicine with the potential to treat the cognitive disorder in 17 years.
The seaweed-based drug, called Oligomannate, can be used for the treatment of mild to moderate Alzheimer's, according to a statement from China's drug safety agency. The approval is conditional however, meaning that while it can go on sale during additional clinical trials, it will be strictly monitored and could be withdrawn should any safety issues arise.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
China says ready to work with ASEAN for South China Sea peaceChina is ready to work with Southeast Asian countries for long term peace and st...
Baca lebih lajut »
China says ready to work with ASEAN for South China Sea peaceChina is ready to work with Southeast Asian countries for long term peace and st...
Baca lebih lajut »
Australia and China vow to work on repairing bilateral relationshipAustralia and China said they will work together to repair their bilateral relat...
Baca lebih lajut »
US-China trade deal in sight after progress in high-level talksThe Chinese Commerce Ministry on Friday said the world's two largest economies had reached 'consensus on principles' during a 'serious and constructive' telephone call between their main trade negotiators.
Baca lebih lajut »
On eve of China import fair, EU warns of 'promise fatigue'The European Union said that China should make rapid and substantial improvement...
Baca lebih lajut »
America and China are sparring over subsidiesThe dispute concerns two of America's biggest gripes: China's economic model and the WTO's inability to constrain it
Baca lebih lajut »